(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LIGEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LIGEN

ST13

US500000088955507

Class

9, 42

Filing

88955507

Registration

6513984

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/21/2023

Trademark type

Combined

Nice classes

9, 42

Filing date

06/09/2020

Registration date

10/12/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/12/2021

Last transaction

04/21/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

Drawing code

3

Owner type

99

Owner location

Milano, IT

Examiner

HACK, ANDREA R

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of light blue rectangle with white chemical drawing image inside the rectangle centered above the word "LiGen" in black lettering.

Holders and representatives

Holders

DOMPE' FARMACEUTICI SPA

Representatives

Kristen McCallion

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

downloadable computer software for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturingtrackingreportinganalyzing health data for use in making informed medical decisions; downloadable virtual reality software for medical teaching; downloadable virtual reality software for medical screening; downloadable computer software platforms for use in database management in the field of medicine; downloadable computer application software for mobile phonessoftware for use in identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; downloadable computer software using artificial intelligence for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models

Class 42

software as a service (SAAS) services featuring software using artificial intelligence for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; providing a website featuring non-downloadable software using artificial intelligence for use in identifying new drugssoftware that is able to screen billions of compounds in a very short time and allows the identification of molecular targetsthe identification and validation of candidate moleculesthe proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software in the field of medicine; design and development of virtual reality software for medical screening; design and development of virtual reality software for medical teaching

Publications

History of USPTO decisions and trademark events.

29 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/27/2021

PUBO

PUBLISHED FOR OPPOSITION

07/27/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/07/2021

ADBS

1(B) BASIS DELETED; NEW BASIS REQUESTED

06/21/2021

ATRQ

ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED

06/19/2021

PCBG

PETITION TO DIRECTOR - CHANGE BASIS - GRANTED

06/19/2021

APET

ASSIGNED TO PETITION STAFF

06/18/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/19/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

05/17/2021

EX1G

SOU EXTENSION 1 GRANTED

05/17/2021

EXT1

SOU EXTENSION 1 FILED

05/17/2021

EEXT

SOU TEAS EXTENSION RECEIVED

05/17/2021

TPAD

TEAS PETITION TO AMEND BASIS RECEIVED

05/17/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

02/09/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/15/2020

PUBO

PUBLISHED FOR OPPOSITION

12/15/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/25/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/09/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/06/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/06/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/15/2020

GNRT

NON-FINAL ACTION E-MAILED

09/15/2020

CNRT

NON-FINAL ACTION WRITTEN

09/15/2020

DOCK

ASSIGNED TO EXAMINER

09/11/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/03/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2020

NWAP

NEW APPLICATION ENTERED

06/12/2020

Continuous trademark protection

Get notified about every new filing that threatens LIGEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.